Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma
Sze Kwan Lam(Queen Mary Hospital), Jcm Ho(Queen Mary Hospital)
Cited by 11
Related Papers
Arsenic trioxide-induced cytotoxicity in small cell lung cancer via altered redox homeostasis and mitochondrial integrity
|International Journal of Oncology|2015|44
Contactin 1 modulates pegylated arginase resistance in small cell lung cancer through induction of epithelial–mesenchymal transition
|Scientific Reports|2019|21
Inhibition of ornithine decarboxylase�1 facilitates pegylated arginase treatment in lung adenocarcinoma xenograft models
|Oncology Reports|2018|19
Tumour growth-suppressive effect of arsenic trioxide in squamous cell lung carcinoma
|Oncology Letters|2017|15